CN109010696A - 治疗前列腺增生的中药组合物及其制备方法 - Google Patents

治疗前列腺增生的中药组合物及其制备方法 Download PDF

Info

Publication number
CN109010696A
CN109010696A CN201811118884.5A CN201811118884A CN109010696A CN 109010696 A CN109010696 A CN 109010696A CN 201811118884 A CN201811118884 A CN 201811118884A CN 109010696 A CN109010696 A CN 109010696A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
radix
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811118884.5A
Other languages
English (en)
Inventor
刘仲永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou Arcadia Medical Management Co Ltd
Original Assignee
Guizhou Arcadia Medical Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guizhou Arcadia Medical Management Co Ltd filed Critical Guizhou Arcadia Medical Management Co Ltd
Priority to CN201811118884.5A priority Critical patent/CN109010696A/zh
Publication of CN109010696A publication Critical patent/CN109010696A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • A61K36/12Filicopsida or Pteridopsida
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及一种治疗前列腺增生的中药组合物,按质量份数计由黄芪1‑6份、当归2‑8份、玛卡2‑8份、淫羊藿2‑8份、牛膝1‑6份、莪术1‑6份、蒲黄1‑6份、瞿麦1‑6份、王不留行1‑6份、蛇舌草1‑6份和半枝莲1‑6份组成。本发明的中药组合物能够升降气机,调整人体阴阳平衡,使机体气血流畅,提高机体抗邪能力,从而使前列腺增生得到改善或治愈。通过各组分相互配伍,补气益肾,通淋化瘀,解毒行滞,以达治疗目的。

Description

治疗前列腺增生的中药组合物及其制备方法
技术领域
本发明属于中药技术领域,涉及一种治疗前列腺增生的中药组合物及其制备方法。
背景技术
前列腺增生症(Benign Prostatic Hyperp Lasia,BPH)是老年男性的常见疾病,中医属于“精癃”、“癃闭”范畴,此病多呈慢性起病,增生的前列腺挤压尿道,导致一系列排尿障碍症状,如尿频尿急、尿流细弱、尿不尽等排尿障碍,患者常因急性尿潴留而到医院就诊。目前,治疗前列腺增生症的药物品种繁多,西医常用保列治、特拉唑嗪治疗,临床多采用中西医结合的方法提高疗效。但它们都有各自的局限性。如果只采用通淋利尿或是补肾壮阳药物,则是标本不得,效果不佳。且一般药物治疗对急性尿潴留一时难奏效。如果采用手术摘除前列腺后问题更复杂,可能给患者带来一定的损害和并发症。因此,本病经药物治疗、手术治疗后复发者多见。且低收入病人常因疗程长费用高而难以坚持。
据报道,男性40岁以上发病率超过30%,发病率随年龄的增加而增加,50岁以上约50%,80~90岁可达80%以上,我国庞大的前列腺增生患者人群以及高昂的医疗费用已经成为一种社会问题。
发明内容
有鉴于此,本发明的目的在于提供一种安全、经济、无毒副作用的治疗前列腺增生的中药组合物及其制备方法。
为达到上述目的,本发明提供如下技术方案:
1.治疗前列腺增生的中药组合物,按质量份数计,由以下成分组成:黄芪1-6份、当归2-8份、玛卡2-8份、淫羊藿2-8份、牛膝1-6份、莪术1-6份、蒲黄1-6份、瞿麦1-6份、王不留行1-6份、蛇舌草1-6份和半枝莲1-6份。
进一步,所述中药组合物按质量份数计,由以下成分组成:黄芪2-5份、当归4-8份、玛卡4-8份、淫羊藿4-8份、牛膝2-6份、莪术2-6份、蒲黄2-6份、瞿麦2-6份、王不留行2-5份、蛇舌草2-5份和半枝莲2-5份。
进一步,所述中药组合物按质量份数计,由以下成分组成:黄芪3-4份、当归4-6份、玛卡6-8份、淫羊藿6-8份、牛膝4-6份、莪术4-6份、蒲黄4-6份、瞿麦4-6份、王不留行3-5份、蛇舌草3-5份和半枝莲3-5份。
进一步,所述中药组合物按质量份数计,由以下成分组成:黄芪4份、当归4份、玛卡8份、淫羊藿8份、牛膝4份、莪术4份、蒲黄4份、瞿麦4份、王不留行5份、蛇舌草5份和半枝莲5份。
2.以上任一项所述的中药组合物的制备方法,将所有组分混合后加1.3-2倍体积的水浸泡0.5-1.5小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
进一步,将所有组分混合后加1.5倍体积的水浸泡1小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
除了水煎服,还可以通过常规的药物制剂方法将所述中药组合物制备成口服液、颗粒冲剂或胶囊。
各中药的药理作用:
黄芪:甘,微温。归肺、脾经。功效与主治:补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
当归:甘、辛,温。归肝、心、脾经。功效与主治:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。
玛卡:辛、甘、温、无毒。归肾、肝、脾经。功效与主治:温肾壮阳,强筋壮骨,散寒、止痛、调血脉。
淫羊藿:辛、甘,温。归肝、肾经。功效与主治:补肾阳,强筋骨,祛风湿。用于肾阳虚衰,阳痿遗精,筋骨痿软,风湿痹痛,麻木拘挛。
牛膝:苦、甘、酸,平。归肝、肾经。功效与主治:逐瘀通经,补肝肾,强筋骨,利尿通淋,引血下行。用于经闭,痛经,腰膝酸痛,筋骨无力,淋证,水肿,头痛,眩晕,牙痛,口疮,吐血,衄血。
莪术:辛、苦,温。归肝、脾经。功效与主治:行气破血,消积止痛。用于癥瘕痞块,瘀血经闭,胸痹心痛,食积胀痛。
蒲黄:甘,平。归肝、心包经。功效与主治:止血,化瘀,通淋。用于吐血,衄血,咯血,崩漏,外伤出血,经闭痛经,胸腹刺痛,跌扑肿痛,血淋涩痛。
瞿麦:苦,寒。归心、小肠经。功效与主治:利尿通淋,活血通经。用于热淋,血淋,石淋,小便不通,淋沥涩痛,经闭瘀阻。
王不留行:苦,平。归肝、胃经。功效与主治:活血通经,下乳消肿,利尿通淋。用于经闭,痛经,乳汁不下,乳痈肿痛,淋证涩痛。
蛇舌草:甘、淡,凉。归胃、肺肠、膀胱经。功能主治清热解毒,利尿消肿,活血止痛。用于肠痈(阑尾炎),疮疖肿毒,湿热黄疸,小便不利等症;外用治疮疖痈肿,毒蛇咬伤。
半枝莲:辛、苦,寒。归肺、肝、肾经。功效与主治:清热解毒,化瘀利尿。用于疔疮肿毒,咽喉肿痛,跌扑伤痛,水肿,黄疸,蛇虫咬伤。
中医认为,前列腺增生的基本病因是肾元亏虚,其基本病机则责之于肾虚血瘀。年老体衰、肾气亏虚是前列腺增生症的发病基础,瘀血、痰浊、湿热是基本的病理因素;本虚标实是基本病机特点:以肾气亏虚为本,瘀血、痰浊聚结为标,血瘀贯穿于病程始终,是前列腺腺体增生病理改变的关键环节,瘀是其中最重要的病因和病理产物。根据气虚血瘀并重、虚实夹杂的病机特点,治疗以通淋化瘀,行气活血中药为主。
本发明的有益效果在于:本发明从病因病机上抓住了前列腺增生是肾气虚导致的前列腺瘀滞,补肾气是治本,化瘀通淋是治标。本发明通过合理配伍,能够升降气机,调整人体阴阳平衡,使机体气血流畅,提高机体抗邪能力,从而使前列腺增生得到抑制和消失。
本发明的中药组合物以黄芪、玛卡、当归、淫羊藿为君药,补气益肾,益气扶正以补其虚。黄芪甘温、入脾肺经,补中益气、升清降浊、为补气要药,并可消散血瘀。以淫羊藿、玛卡补肾壮阳,强筋壮骨。以当归补血活血;以莪术、蒲黄、瞿麦和王不留行为臣药,通淋化瘀,行气活血,以莪术行气活血,蒲黄祛瘀通淋,瞿麦、王不留行利尿通淋,君臣二药为伍互补;以蛇舌草、半枝莲为佐解毒行瘀;以牛膝为使活血、引药下行使药物作用于病所。本发明的中药组合物通过各成分相互配伍,共凑益气、活血、散结、利湿等功效,以达治疗目的。安全无毒副作用,使用本发明治疗前列腺增生效果显著且费用少。避免了手术治疗的高风险和高费用,也解决了中药治疗经久不愈的问题。目前治疗前列腺增生症的药物品种繁多,且都有不错的疗效,但它们都有各自的局限性。而本发明在补肾益气的同时,更针对湿热及瘀血阻塞尿路的病因,从而减轻前列腺因充血所致的肿大,尿道受压所致的排尿困难,改善患者的生活质量,达到标本同治的效果,且无明显不良反应,在前列腺增生领域有广阔的临床应用前景。
具体实施方式
下面对本发明的优选实施例进行详细的描述。实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。
实施例1
一种治疗前列腺增生的中药组合物,按每日用量由以下组分组成:
黄芪12g、当归12g、玛卡24g、淫羊藿24g、牛膝12g、莪术12g、蒲黄12g、瞿麦12g、王不留行15g、蛇舌草15g和半枝莲15g。
将上述中药材粉碎后用50%乙醇溶液热回流提取2次(1h/次),料液比1:20,抽滤后合并滤液,再减压浓缩至1/5-1/10。
实施例2
一种治疗前列腺增生的中药组合物,由以下组分组成:
黄芪16g、当归16g、玛卡20g、淫羊藿20g、牛膝20g、莪术20g、蒲黄20g、瞿麦20g、王不留行16g、蛇舌草16g和半枝莲16g。
将所有混合后加1.3-2倍体积的水浸泡0.5-1.5小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可,上述药方为一日一剂,药汁均分早晚服用。
将上述中药材粉碎后用水萃取有效成分,通过常规的药物制剂方法将所述中药组合物制备成口服液、颗粒冲剂或胶囊。
实施例3
一种治疗前列腺增生的中药组合物,按质量份数计由以下组分组成:
黄芪12g、当归20g、玛卡24g、淫羊藿24g、牛膝20g、莪术20g、蒲黄12g、瞿麦12g、王不留行12g、蛇舌草12g和半枝莲12g。
实施例4
一种治疗前列腺增生的中药组合物,按质量份数计由以下组分组成:
黄芪9g、当归18g、玛卡24g、淫羊藿24g、牛膝12g、莪术12g、蒲黄15g、瞿麦15g、王不留行15g、蛇舌草15g和半枝莲15g。
实施例5
雄性SPF级SD大鼠,60只,体重200~250g,笼内饲养,正常采光,自由饮食饮水。随机分为正常组,模型组,中药复方高剂量组、中药复方低剂量组和阳性对照组。将大鼠麻醉后75%酒精消毒,经阴囊摘除双侧睾丸,残端处结扎确保止血,缝合皮肤后肌肉注射青霉素20万U/只,连续3天。1周后,除正常组外,其余大鼠每天皮下注射丙酸睾丸酮0.5mg/0.02mL,一天一次,连续15天;注射针头需保证无菌、无水,并同时分别灌胃给药;正常组和模型组以生理盐水0.5mL/100g体重灌胃;取实施例1所制备的中药组合物提取物,按中药复方高剂量组给予500mg/(kg·d)灌胃,中药复方低剂量组给予150mg/(kg·d)灌胃,阳性对照组灌胃非那雄胺1mg/(kg·d),连续用药30天。
最后一次给药8小时后,再禁食12h,称取各组大鼠质量,脱颈椎处死后解剖腹腔,下腔静脉取血,分离血清,用酶联免疫方法测定大鼠血清中二氢睾酮、睾酮和雌二醇水平,测定结果如表1所示。再分离出大鼠前列腺,用分析天平称重,计算前列腺指数=前列腺湿质量(mg)/体质量(g),其数值越大前列腺增生情况越严重,测定结果如表2所示。
表1各组大鼠血清激素水平变化
与模型组比较,*P<0.05
与模型组相比,中药复方高剂量组、中药复方低剂量组、阳性对照组的大鼠血清中的二氢睾酮的含量均有显著下降(P<0.05),且中药复方高剂量组的睾酮、睾酮/雌二醇值亦有明显下降(P<0.05)。
表2中药组合物提取物对大鼠前列腺指数的影响
与模型组比较,*P<0.05
由表2可知,大鼠前列腺增生模型造模成功,阳性对照组和中药复方组均显著降低增生前列腺的质量,P<0.05。说明本发明的中药组合物能限制降低或抑制前列腺增生。
最后说明的是,以上优选实施例仅用以说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。

Claims (6)

1.治疗前列腺增生的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪1-6份、当归2-8份、玛卡2-8份、淫羊藿2-8份、牛膝1-6份、莪术1-6份、蒲黄1-6份、瞿麦1-6份、王不留行1-6份、蛇舌草1-6份和半枝莲1-6份。
2.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪2-5份、当归4-8份、玛卡4-8份、淫羊藿4-8份、牛膝2-6份、莪术2-6份、蒲黄2-6份、瞿麦2-6份、王不留行2-5份、蛇舌草2-5份和半枝莲2-5份。
3.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪3-4份、当归4-6份、玛卡6-8份、淫羊藿6-8份、牛膝4-6份、莪术4-6份、蒲黄4-6份、瞿麦4-6份、王不留行3-5份、蛇舌草3-5份和半枝莲3-5份。
4.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪4份、当归4份、玛卡8份、淫羊藿8份、牛膝4份、莪术4份、蒲黄4份、瞿麦4份、王不留行5份、蛇舌草5份和半枝莲5份。
5.权利要求1-4任一项所述的中药组合物的制备方法,其特征在于,将所有药材组分混合后加1.3-2倍体积的水浸泡0.5-1.5小时,用文火煎熬20-40分钟,过滤出药汁备用;
药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
6.根据权利要求5所述的制备方法,其特征在于,将所有药材组分混合后加1.5倍体积的水浸泡1小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
CN201811118884.5A 2018-09-25 2018-09-25 治疗前列腺增生的中药组合物及其制备方法 Withdrawn CN109010696A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811118884.5A CN109010696A (zh) 2018-09-25 2018-09-25 治疗前列腺增生的中药组合物及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811118884.5A CN109010696A (zh) 2018-09-25 2018-09-25 治疗前列腺增生的中药组合物及其制备方法

Publications (1)

Publication Number Publication Date
CN109010696A true CN109010696A (zh) 2018-12-18

Family

ID=64618229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811118884.5A Withdrawn CN109010696A (zh) 2018-09-25 2018-09-25 治疗前列腺增生的中药组合物及其制备方法

Country Status (1)

Country Link
CN (1) CN109010696A (zh)

Similar Documents

Publication Publication Date Title
CN102166317B (zh) 一种治疗崩漏的中药组合物
CN105327205A (zh) 一种治疗甲状腺癌的中药制剂
CN101757591B (zh) 一种治疗慢性结肠炎、直肠炎的中药组合物
CN102772712B (zh) 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物
CN106728863A (zh) 一种治疗糖尿病的中药及其制备方法
CN101607067B (zh) 一种治疗胆结石的中药制剂及制备方法
CN103341010A (zh) 一种治疗黄疸型肝炎的中药制剂及制备方法
CN103212020B (zh) 一种治疗功能性消化不良的中药组合物
CN104784245A (zh) 一种治疗宫颈癌的药物
CN104706919B (zh) 一种治疗体表溃疡的药物组合物
CN109010696A (zh) 治疗前列腺增生的中药组合物及其制备方法
CN105770691A (zh) 一种用于治疗宫颈癌的药物制剂及其用途
CN102038889B (zh) 治疗风湿性心脏病的中药
CN105168946A (zh) 一种治疗糖尿病的中药组合物及其用途
CN105031505A (zh) 一种治疗良性前列腺增生肥大的药物及其制备方法
CN109602838A (zh) 一种治疗慢性炎症的中药组合物及其制备方法和应用
CN104225016A (zh) 一种治疗脾胃虚弱型慢性萎缩性胃炎的药物组合物
CN107961355A (zh) 一种治疗肝腹水的肚脐丸及其制备方法
CN103301374B (zh) 一种治疗产后非特异性阴道炎的药物组合物
CN105999196A (zh) 一种用于治疗急性腹膜炎的中药制剂及制备方法
CN105381273A (zh) 一种治疗糖尿病的药物组合物及其用途
CN104758421A (zh) 一种治疗肝气郁结症慢性前列腺炎的艾可合剂及制备方法
CN105327299A (zh) 一种用于治疗原发性血小板减少紫癜的药物
CN105709005A (zh) 一种乳康丸
CN106266970B (zh) 一种治疗生产引发子宫内膜炎的中药组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20181218

WW01 Invention patent application withdrawn after publication